AI/Machine Learning: Regulation, Development, and Real-World Performance Evaluation
Webinar | 03.22.22, 12:30 PM UTC - 4:00 PM UTC
On March 22, 2022 from 12:30 – 4:00 pm (EDT) the Duke-Margolis Center of Health Policy, with participation from the U.S. Food and Drug Administration (FDA) speakers and panelists, will hold a public webinar to spotlight updates and progress made since the release of FDA’s Artificial Intelligence/Machine Learning Action Plan in early 2021.
There will be a fireside chat between Jeff Shuren, FDA’s director of the Center for Devices and Radiological Health (CRDH), and Mark McClellan, director of Duke-Margolis, followed by three panel discussions focused on the following topics:
- Overarching frameworks for regulating and evaluating AI
- Good machine learning practices (GMLP)
- Post-market evaluation of AI/ML SaMD
The webinar will end with a business roundtable discussion on how developers and health care systems are considering these issues.
For more information, please visit these areas: Artificial Intelligence
Participants
Partner & CHS Managing Director
She/Her/Hers
Insights
Webinar | 02.25.25
First 100 Days: Navigating New Frontiers: Life Sciences in the Trump Era
Please join us for a post-Election webinar with the heads of our Government Affairs group who will address the myriad of areas in the Life Sciences industry that will likely be impacted by the new administration, including FDA, NIH, drug pricing, imports, and exports.
Webinar | 02.20.25
